ICD-10 Coding for Immunodeficiency(B96.2U, D80.1, D80.1U)
Explore detailed ICD-10 coding guidelines for immunodeficiency, including drug-induced and common variable immunodeficiency. Learn about documentation requirements and coding pitfalls.
Complete code families applicable to Immunodeficiency
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| D83.0 | Common Variable Immunodeficiency with predominant abnormalities of B-cell numbers and function | Use when CVID is confirmed by lab tests showing low IgG and poor vaccine response. |
|
| D84.821 | Immunodeficiency due to drugs | Use when immunodeficiency is directly linked to drug therapy. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutImmunodeficiency
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Immunodeficiency.
Vague documentation of immune status.
Impact
Clinical: May lead to misdiagnosis., Regulatory: Non-compliance with documentation standards., Financial: Potential for claim denials.
Mitigation
Use specific lab values and clinical findings., Link drug use to immunodeficiency.
Using unspecified codes when specific cause is known.
Impact
Reimbursement: May lead to reduced reimbursement rates., Compliance: Non-compliance with coding guidelines., Data Quality: Decreases accuracy of health data.
Mitigation
Use specific codes like D84.821 for drug-induced cases.
Incorrect code sequencing
Impact
Failure to sequence underlying conditions before immunodeficiency.
Mitigation
Educate coding staff on proper sequencing rules.
Frequently Asked Questions
Primary Code
Common Variable Immunodeficiency with predominant abnormalities of B-cell numbers and functio